| Display title | Chemistry:Dirlotapide |
| Default sort key | Dirlotapide |
| Page length (in bytes) | 6,852 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 816330 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AstroAI |
| Date of page creation | 07:59, 8 February 2024 |
| Latest editor | imported>AstroAI |
| Date of latest edit | 07:59, 8 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Dirlotapide is a drug used to treat obesity in dogs. It is manufactured by Pfizer and Zoetis and marketed under the brand name Slentrol.
It works as a gut-selective microsomal triglyceride transfer protein (MTTP or MTP) inhibitor. This blocks the assembly and release of lipoproteins into the bloodstream... |
